For both formulations, RSV (1.0 mg/mL) was incorporated into the hydrophobic phase using chloroform
29 This condition is characterized by rapid heartbeat, sweating, nervousness, tremors, muscle weakness, sleep difficulties, increased appetite, and sudden weight loss
Pexips technology aligns with DISAs need for customized user interfaces and flexible deployment options across multiple global time zones and missions
10 Vials in divided doses over 1 month for weight loss, anti-aging, and health other management
These assets aim to move beyond the current weekly injection paradigm, signalling a future where extended dosing intervals could become central to maintenance strategies [16]